<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) constitute a <z:e sem="disease" ids="C0282313" disease_type="Neoplastic Process" abbrv="">preneoplastic condition</z:e> in which potentially malignant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells continuously die during differentiation </plain></SENT>
<SENT sid="1" pm="."><plain>This <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-associated cell <z:hpo ids='HP_0011420'>death</z:hpo> often involves caspase-3 activation, yet can also occur without caspase activation, for instance in differentiating megakaryocytes (MK) </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated, the mechanisms through which MK from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients undergo premature cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>While polyploid, mature MK from healthy subjects or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients manifested caspase-3 activation during terminal differentiation, freshly isolated, immature MK from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> died without caspase-3 activation </plain></SENT>
<SENT sid="4" pm="."><plain>Similarly, purified bone marrow CD34(+) cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients that were driven into MK differentiation in vitro died without caspase-3 activation at an immature stage, before polyploidization </plain></SENT>
<SENT sid="5" pm="."><plain>The premature <z:hpo ids='HP_0011420'>death</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> MK was accompanied by the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> release of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi>, Smac/DIABLO and endonuclease G, a caspase-independent <z:hpo ids='HP_0011420'>death</z:hpo> effector, as well loss of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential and plasma membrane phosphatidylserine exposure before definitive loss of viability </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, a stereotyped pattern of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> alterations accompanies differentiation-associated MK <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>